Immunoregulatory functions of mTOR inhibition

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Nature reviews. Immunology

• Publication date

  2009-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nri2546PMID 19390566PMCID PMC2847476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of Sirolimus in Solid Organ Transplantation

  2012cited by this paper
• Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells

  2009cited by this paper
• Participation of mTOR Complex 1 in TLR2 and TLR4 Induced Neutrophil Activation and Acute Lung Injury.

  2009cited by this paper
• Macroautophagy in Immunity and Tolerance

  2009cited by this paper
• Rapamycin Prevents and Breaks the Anti-CD3–Induced Tolerance in NOD Mice

  2009cited by this paper
• Participation of mammalian target of rapamycin complex 1 in Toll-like receptor 2- and 4-induced neutrophil activation and acute lung injury.

  2009cited by this paper
• An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1*

  2009cited by this paper
• Regulatory T cells and immune tolerance.

  2008cited by this paper
• Delivery of rapamycin-loaded nanoparticle down regulates ICAM-1 expression and maintains an immunosuppressive profile in human CD34+ progenitor-derived dendritic cells.

  2008cited by this paper
• Delivery of rapamycin to dendritic cells using degradable microparticles

  2008cited by this paper
• The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells

  2008cited by this paper
• Cutting Edge: Foxp3-Mediated Induction of Pim 2 Allows Human T Regulatory Cells to Preferentially Expand in Rapamycin1

  2008cited by this paper
• Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells

  2008cited by this paper
• Use of Sirolimus in IPEX and IPEX-Like Children

  2008cited by this paper
• Toll-like receptor–mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway

  2008cited by this paper
• The known unknowns of antigen processing and presentation

  2008cited by this paper
• Interleukin-2 receptor downstream events in regulatory T cells: Implications for the choice of immunosuppressive drug therapy

  2008cited by this paper
• Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells.

  2008cited by this paper
• Prolongation of Cardiac and Islet Allograft Survival by a Blocking Hamster Anti-Mouse CXCR3 Monoclonal Antibody

  2008cited by this paper
• Translational control of the innate immune response through IRF-7

  2008cited by this paper
• Use of sirolimus (rapamycin) to treat refractory Crohn’s disease

  2008cited by this paper
• Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.

  2008cited by this paper
• Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning.

  2008cited by this paper
• The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model.

  2008cited by this paper
• WNT signalling in the immune system: WNT is spreading its wings

  2008cited by this paper
• Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer

  2008cited by this paper
• Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice.

  2008cited by this paper
• Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma.

  2008cited by this paper
• Correlation of dendritic cell maturation and the formation of aggregates of poly-ubiquitinated proteins in the cytosol

  2008cited by this paper
• Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells.

  2008cited by this paper
• A two-step process for thymic regulatory T cell development.

  2008cited by this paper
• T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR

  2008cited by this paper
• IL-1β-Driven ST2L Expression Promotes Maturation Resistance in Rapamycin-Conditioned Dendritic Cells1

  2008cited by this paper
• Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4+CD25+FOXP3+ Regulatory T-Cells

  2008cited by this paper
• Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking

  2008cited by this paper
• Impact of Mammalian Target of Rapamycin Inhibition on Lymphoid Homing and Tolerogenic Function of Nanoparticle-Labeled Dendritic Cells following Allogeneic Hematopoietic Cell Transplantation1

  2008cited by this paper
• STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells.

  2008cited by this paper
• Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire.

  2008cited by this paper
• Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells.

  2008cited by this paper
• Hypoxia stimulus: An adaptive immune response during dendritic cell maturation.

  2008cited by this paper
• Effects of Immunosuppressive Drugs On Purified Human B Cells: Evidence Supporting the Use of MMF and Rapamycin

  2008cited by this paper
• The TSC-mTOR signaling pathway regulates the innate inflammatory response.

  2008cited by this paper
• Foxp3 in control of the regulatory T cell lineage

  2007cited by this paper
• Interleukin-2 receptor signaling in regulatory T cell development and homeostasis.

  2007cited by this paper
• Selective Survival of Naturally Occurring Human CD4+CD25+Foxp3+ Regulatory T Cells Cultured with Rapamycin1

  2007cited by this paper
• Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes.

  2007cited by this paper
• Rapamycin-Conditioned Dendritic Cells Are Poor Stimulators of Allogeneic CD4+ T Cells, but Enrich for Antigen-Specific Foxp3+ T Regulatory Cells and Promote Organ Transplant Tolerance1

  2007cited by this paper
• Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML.

  2007cited by this paper
• Prevention of murine lupus disease in (NZB×NZW)F1 mice by sirolimus treatment

  2007cited by this paper
• Expanding mTOR signaling

  2007cited by this paper
• mTOR at the crossroads of T cell proliferation and tolerance.

  2007cited by this paper
• The kinases aurora B and mTOR regulate the G1–S cell cycle progression of T lymphocytes

  2007cited by this paper
• Current therapy for autoimmune hepatitis

  2007cited by this paper
• Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans

  2007cited by this paper
• Inhibition of endogenous MHC class II‐restricted antigen presentation by tacrolimus (FK506) via FKBP51

  2007cited by this paper
• Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.

  2007cited by this paper
• Deacetylase inhibition promotes the generation and function of regulatory T cells

  2007cited by this paper
• Distinct signaling mechanisms activate the target of rapamycin in response to different B‐cell stimuli

  2007cited by this paper
• Regulatory T cells and T cell depletion: role of immunosuppressive drugs.

  2007cited by this paper
• Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation.

  2007cited by this paper
• PSGL‐1 and mTOR regulate translation of ROCK‐1 and physiological functions of macrophages

  2007cited by this paper
• Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+CD25+FoxP3+ T cells

  2007cited by this paper
• Contrasting Effects of Cyclosporine and Rapamycin in De Novo Generation of Alloantigen‐Specific Regulatory T Cells

  2007cited by this paper
• Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer

  2006cited by this paper
• mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt.

  2006cited by this paper
• Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells.

  2006cited by this paper
• Rapamycin-Mediated Enrichment of T Cells with Regulatory Activity in Stimulated CD4+ T Cell Cultures Is Not Due to the Selective Expansion of Naturally Occurring Regulatory T Cells but to the Induction of Regulatory Functions in Conventional CD4+ T Cells1

  2006cited by this paper
• Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients1

  2006cited by this paper
• mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s.

  2006cited by this paper
• Differential Effects of Immunosuppressive Drugs on Chemokine Receptor CCR7 in Human Monocyte-Derived Dendritic Cells: Selective Upregulation by Rapamycin

  2006cited by this paper
• Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

  2006cited by this paper
• Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.

  2006cited by this paper
• mTOR and cancer: insights into a complex relationship

  2006cited by this paper
• Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production.

  2006cited by this paper
• Induction of Tolerance in Type 1 Diabetes via Both CD4+CD25+ T Regulatory Cells and T Regulatory Type 1 Cells

  2006cited by this paper
• TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth.

  2006cited by this paper
• Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance.

  2006cited by this paper
• TOR signaling in growth and metabolism.

  2006cited by this paper
• Intracellular network of phosphatidylinositol 3‐kinase, mammalian target of the rapamycin/70 kDa ribosomal S6 kinase 1, and mitogen‐activated protein kinases pathways for regulating mycobacteria‐induced IL‐23 expression in human macrophages

  2006cited by this paper
• Lymphoid Sequestration of Alloreactive Memory CD4 T Cells Promotes Cardiac Allograft Survival1

  2006cited by this paper
• PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs.

  2006cited by this paper
• Prolonged TCR/CD28 Engagement Drives IL-2-Independent T Cell Clonal Expansion through Signaling Mediated by the Mammalian Target of Rapamycin1

  2006cited by this paper
• Calcineurin Inhibitors, but not Rapamycin, Reduce Percentages of CD4+CD25+FOXP3+ Regulatory T Cells in Renal Transplant Recipients

  2006cited by this paper
• Defective Activation of Protein Kinase C and Ras-ERK Pathways Limits IL-2 Production and Proliferation by CD4+CD25+ Regulatory T Cells1

  2006cited by this paper
• Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation.

  2006cited by this paper
• Novel roles of Akt and mTOR in suppressing TGF‐β/ALK5‐mediated Smad3 activation

  2006cited by this paper
• Growing roles for the mTOR pathway.

  2005cited by this paper
• Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

  2005cited by this paper
• Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.

  2005cited by this paper
• Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells.

  2005cited by this paper
• The Pim kinases control rapamycin-resistant T cell survival and activation

  2005cited by this paper
• mTOR·RICTOR Is the Ser473 Kinase for Akt/Protein Kinase B in 3T3-L1 Adipocytes*

  2005cited by this paper
• Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.

  2005cited by this paper
• IRF-7 is the master regulator of type-I interferon-dependent immune responses

  2005cited by this paper
• Rapamycin‐Treated, Alloantigen‐Pulsed Host Dendritic Cells Induce Ag‐Specific T Cell Regulation and Prolong Graft Survival

  2005cited by this paper
• IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

  2005cited by this paper
• The Solution Structure of the FATC Domain of the Protein Kinase Target of Rapamycin Suggests a Role for Redox-dependent Structural and Cellular Stability*

  2005cited by this paper
• Drug eluting stents: an updated meta-analysis of randomised controlled trials

  2005cited by this paper
• RAPAMYCIN PROTECTS ALLOGRAFTS FROM REJECTION WHILE SIMULTANEOUSLY ATTACKING TUMORS IN IMMUNOSUPPRESSED MICE

  2004cited by this paper
• The Novel Cyclophilin Binding Compound, Sanglifehrin A, Disassociates G1 Cell Cycle Arrest from Tolerance Induction1

  2004cited by this paper

• Post-Transplant Hepatocellular Carcinoma: Balancing Immunosuppression and Immune Checkpoint Inhibitors.

  2026cites this paper
• Viral infections in solid organ transplant recipients: immunological principles and intervention strategies.

  2026cites this paper
• Drug-controlled CAR T cells through the regulation of cell-cell interactions.

  2026cites this paper
• Dietary ferulic acid boosts the immunity and antioxidant activity of T lymphocytes in Nile tilapia (Oreochromis niloticus) challenged with Aeromonas hydrophila.

  2026cites this paper
• Chemical activation of mitophagy via the N-degron pathway alleviates mitochondrial neuropathies

  2026cites this paper
• Nanomedicine meets transplantation: Unlocking precision therapeutics for organ rejection

  2026cites this paper
• Immunomodulation of behavior impairment via spleen-specific targeting lipid nanoparticles in a MeCP2 transgenic mouse model

  2025cites this paper
• Metabolic Reprogramming of Adaptive Immunity Induced by Viral Infections

  2025cites this paper
• mTOR Inhibition limits LPS induced acute kidney injury and ameliorates hallmarks of cellular senescence

  2025cites this paper
• A review on mTOR inhibitor use and outcomes of COVID-19 among patients with kidney transplantation

  2025cites this paper
• Transplant oncology and anti-cancer immunosuppressants

  2025cites this paper
• Pharmacodynamic effect of mTOR inhibition-based immunosuppressive therapy on dendritic cell and natural killer cell subsets after renal transplantation.

  2025cites this paper
• The effects of policosanol supplementation on creatinine: a systematic review and dose–response meta-analysis of randomized controlled trials

  2025cites this paper
• Muscle loss in cancer cachexia: what is the basis for nutritional support?

  2025cites this paper
• The role of mTOR signaling pathway in systemic lupus erythematosus and systemic vasculitis.

  2025cites this paper
• A fundamental relationship between TCR diversity, repertoire size and systemic clonal expansion: insights from 30,000 TCRβ repertoires

  2025cites this paper
• mTORC1 inhibition by sirolimus as adjunctive treatment in experimental pneumococcal meningitis

  2025cites this paper
• Multicenter phase 1/2 study of onatasertib, a dual TORC1/2 inhibitor, combined with the PD-1 antibody toripalimab in advanced solid tumors

  2025cites this paper
• T-regulatory cells for the treatment of autoimmune diseases

  2025cites this paper
• A Network Meta-Analysis on the Impact of Sirolimus vs. Everolimus on Malignancies After Kidney Transplantation

  2025cites this paper
• Sirolimus Plus Low‐Exposure Calcineurin Inhibitors as an Alternative Graft‐Versus‐Host Disease Prophylaxis in Calcineurin Inhibitor‐Intolerant Recipients: A Retrospective Study

  2025cites this paper
• Comprehensive Physiological and Transcriptomic Profiling of Triploid Pacific Oysters (Crassostrea gigas) Under Ammonia Exposure

  2025cites this paper
• Eisenia bicyclis Extract Ameliorates Colitis in In Vitro and In Vivo Models Through Modulation of mTOR Axis and Gut Microbiota Composition

  2025cites this paper
• Exosomes from systemic lupus erythematosus (SLE) patients Facilitate the production of inflammatory cytokines in dendritic cells (DCs) by regulating the mTOR signaling.

  2025cites this paper
• Crosstalk Between Autophagy and Oxidative Stress in Hematological Malignancies: Mechanisms, Implications, and Therapeutic Potential

  2025cites this paper
• Late-onset pneumocystis pneumonia after kidney transplantation: A systematic review and meta-analysis of prevalence, risk factors, and outcomes.

  2025cites this paper
• A Systematic Review of the Efficacy and Safety of Sirolimus (Rapamycin) in the Management of Infantile Hemangioma

  2025cites this paper
• Spleen‐Targeting Biomimetic Hybrid Nanocarriers for Systemic Immune Reprogramming in Colitis: RBC Membrane Vesicle‐Fused Lipid Nanoparticles

  2025cites this paper
• Exploring the role of mTOR pathway in aging and age-related disorders

  2025cites this paper
• Current Insights of the Potential Plant Bioactive Compounds on Modulating the mTOR Signaling Pathway in Regulating Oncological Disorders

  2025cites this paper
• Side Effects of Immunosuppressant Drugs After Liver Transplant

  2025cites this paper
• Lysosomal and mTORC1 signaling dysregulation underpin the pathology of spastic paraplegia type 80

  2025cites this paper
• The Use of Ketamine for the Treatment of Anhedonia in Depression

  2024cites this paper
• Neuroinflammation and autism: what have we learned so far?

  2024cites this paper
• Optimal Practices in the Delivery of Aesthetic Medical Care to Patients on Immunosuppressants and Immunomodulators: A Systematic Review of the Literature.

  2024cites this paper
• Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma

  2024cites this paper
• Interleukin-6 induces nascent protein synthesis in human dorsal root ganglion nociceptors primarily via MNK-eIF4E signaling

  2024cites this paper
• Relationship between immune cells and the development of chronic lung allograft dysfunction.

  2024cites this paper
• Status of islet transplantation and innovations to sustainable outcomes: novel sites, cell sources, and drug delivery strategies

  2024cites this paper
• Negative Vaccination Strategies for Promotion of Transplant Tolerance

  2024cites this paper
• A structured biomimetic nanoparticle as inflammatory factor sponge and autophagy-regulatory agent against intervertebral disc degeneration and discogenic pain

  2024cites this paper
• Tolerance-inducing therapies in coeliac disease — mechanisms, progress and future directions

  2024cites this paper
• Rapamycin immunomodulation utilizes time-dependent alterations of lymph node architecture, leukocyte trafficking, and gut microbiome

  2024cites this paper
• Rapamycin improves the long-term T-cell memory and protective efficacy of tuberculosis subunit vaccine.

  2024cites this paper
• Everolimus treatment enhances inhibitory immune checkpoint molecules' expression in monocyte-derived dendritic cells.

  2024cites this paper
• A loss of primary cilia by a reduction in mTOR signaling correlates with age-related deteriorations in condylar cartilage

  2024cites this paper
• Advancing immunosuppression in liver transplantation: the role of regulatory T cells in immune modulation and graft tolerance

  2024cites this paper
• Protein neddylation and its role in health and diseases

  2024cites this paper
• Facile synthesis of rapamycin‐loaded PEG‐b‐PLA nanoparticles and their application in immunotherapy

  2024cites this paper
• Oxymatrine combined with rapamycin to attenuate acute cardiac allograft rejection

  2024cites this paper
• RAD001-mediated mTOR targeting in human monocyte-derived dendritic cells shifts them toward an immunogenic phenotype

  2024cites this paper
• Chemoproteomic development of SLC15A4 inhibitors with anti-inflammatory activity

  2024cites this paper
• The pivotal role of autophagy in the pathogenesis and therapy of medulloblastoma.

  2024cites this paper
• Non‐invasive molecular biomarkers for monitoring solid organ transplantation: A comprehensive overview

  2024cites this paper
• Immunomodulatory potential of primary cilia in the skin

  2024cites this paper
• Fecal Microbiota Transplantation Alleviates Allergic Rhinitis via CD4+ T Cell Modulation Through Gut Microbiota Restoration

  2024cites this paper
• A Paradoxical AKT: Exploring the Promise and Challenges of PI3K/AKT/mTOR Targeted Therapies

  2024cites this paper
• Advances in Immune Tolerance Induction in Enzyme Replacement Therapy

  2024cites this paper
• Belatacept and regulatory T cells in transplantation: synergistic strategies for immune tolerance and graft survival

  2024cites this paper
• Coronary stent implantation links to the occurrence of eosinophilia and interstitial pneumonia: a case report and systematic review

  2024cites this paper
• Transient Inhibition of Translation Improves Cardiac Function After Ischemia/Reperfusion by Attenuating the Inflammatory Response

  2024cites this paper
• Mitochondrial Dysfunction in Systemic Lupus Erythematosus: Insights and Therapeutic Potential

  2024cites this paper
• Tolerogenic Nano-/Microparticle Vaccines for Immunotherapy.

  2024cites this paper
• T cell involvement in antiphospholipid syndrome.

  2024cites this paper
• Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research

  2024cites this paper
• Cutting edge of immune response and immunosuppressants in allogeneic and xenogeneic islet transplantation

  2024cites this paper
• Protection by selective mTORC2 inhibition of Zymosan-induced hypotension and systemic inflammation mediated via IKKα/IκB-α/NF-κB activation.

  2024cites this paper
• Immunomodulation of T cell-mediated Alloimmunity by Proximity to Endothelial Cells under mTOR Blockade.

  2024cites this paper
• mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment

  2024cites this paper
• Post‐transplant lymphoproliferative disease in children, adolescents, and young adults

  2023cites this paper
• Lymphocyte Depleting and Modulating Therapies for Chronic Lung Allograft Dysfunction

  2023cites this paper
• The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma

  2023cites this paper
• Spi1 regulates the microglial/macrophage inflammatory response via the PI3K/AKT/mTOR signaling pathway after intracerebral hemorrhage

  2023cites this paper
• Unforeseen consequences of synergizing PEGylated rapamycin and quercetin in angiogenesis and metastasis inhibition: Turning failure into benefit

  2023cites this paper
• Intervertebral disc cell fate during aging and degeneration: apoptosis, senescence, and autophagy.

  2023cites this paper
• Targeting regulatory T cell metabolism in disease: Novel therapeutic opportunities

  2023cites this paper
• Detection of Novel Biomarkers in Pediatric Autoimmune Hepatitis by Proteomic Profiling

  2023cites this paper
• Biomaterials-based immunomodulation enhances survival of murine vascularized composite allografts.

  2023cites this paper
• Effect of sirolimus on insulin dynamics in horses

  2023cites this paper
• Ketamine-Associated Change in Anhedonia and mTOR Expression in Treatment-Resistant Depression.

  2023cites this paper
• The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis

  2023cites this paper
• Research progress of ophthalmic preparations of immunosuppressants

  2023cites this paper
• Different Patterns of Foxp3 Gene Expression in Pre-and Post-Transplantation Kidney Biopsies and the Effect of Use Mammalian Target of Rapamycin Inhibitors.

  2023cites this paper
• Natural product ligands of FKBP12: Immunosuppressive antifungal agents FK506, rapamycin, and beyond

  2023cites this paper
• Cardiac Autoantibodies Against Cardiac Troponin I in Post-Myocardial Infarction Heart Failure: Evaluation in a Novel Murine Model and Applications in Therapeutics

  2023cites this paper
• Targeting the mammalian target of rapamycin pathway in neurological manifestations of Covid‐19

  2023cites this paper
• Exploring the synthetic approaches and clinical prowess of established macrocyclic pharmaceuticals.

  2023cites this paper
• The mitochondriogenic but not the immunosuppressant effects of mTOR inhibitors prompt neuroprotection and delay disease evolution in a mouse model of progressive multiple sclerosis.

  2023cites this paper
• Biodegradable AZ91 magnesium alloy/sirolimus/poly D, L-lactic-co-glycolic acid-based substrate for cardiovascular device application.

  2023cites this paper
• A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia

  2023cites this paper
• Lymphangioleiomyomatosis Showing the Development of Mycobacterium abscessus subsp. massiliense Infection during Sirolimus Therapy

  2023cites this paper
• Difficult-to-Treat Rejections in Kidney Transplant Recipients: Our Experience with Everolimus-Based Quadruple Maintenance Therapy

  2023cites this paper
• Exopolysaccharide-treated Dendritic Cells Effectively Ameliorate Acute Graft vs Host Disease.

  2023cites this paper
• Post-transcriptional regulation of myeloid cell-mediated inflammatory responses.

  2023cites this paper
• mTORC1 inhibition may improve T lymphocytes affected by aging

  2023cites this paper
• Abatacept and T-cell costimulation blockade—shifting the paradigm in the prevention of graft-versus-host disease

  2023cites this paper
• PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors

  2023cites this paper
• Role of mTORC1 Signaling in Regulating the Immune Function of Granulocytes in Teleost Fish

  2023cites this paper
• Pinellia ternata lectin induces inflammation through TLR4 receptor and mediates PI3K/Akt/mTOR axis to regulate NF-κB signaling pathway.

  2023cites this paper
• Peripheral Blood DNA Methylation Signatures and Response to Tofacitinib in Moderate-to-severe Ulcerative Colitis

  2023cites this paper